Akoya Biosciences, Inc. (AKYA)

Akoya Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	83.82	74.53	113.38	17.01	21.66
Short-Term Investments	0	6.99	0	0	0
Cash & Cash Equivalents	83.82	81.52	113.38	17.01	21.66
Cash Growth	2.83%	-28.10%	566.71%	-21.48%	-
Receivables	16.99	9.73	9.44	6.47	13.17
Inventory	18.77	16.57	11.56	5.76	4.57
Other Current Assets	2.2	4.38	6.43	-0.54	1.48
Total Current Assets	121.79	112.2	140.81	28.7	40.87
Property, Plant & Equipment	20.66	22.45	7.49	5.53	4.98
Long-Term Investments	0	0	0	0.5	0.5
Goodwill and Intangibles	35.67	38.31	39.41	40.98	42.4
Other Long-Term Assets	2.25	3.08	3.19	1.96	0.66
Total Long-Term Assets	58.58	63.83	50.09	48.96	48.54
Total Assets	180.37	176.03	190.91	77.66	89.41
Accounts Payable	11.78	10.63	9.44	5.07	8.12
Deferred Revenue	9.88	8.39	5.81	4.85	5.28
Current Debt	3.45	3.63	0.27	1.23	0.08
Other Current Liabilities	10.24	14.41	12.16	6.01	7.68
Total Current Liabilities	35.35	37.06	27.68	17.16	21.16
Long-Term Debt	82.26	72.16	32.67	33.77	24.67
Other Long-Term Liabilities	9	8.24	9.21	8.65	9.4
Total Long-Term Liabilities	91.25	80.4	41.87	42.42	34.07
Total Liabilities	126.6	117.45	69.56	59.58	55.23
Total Debt	85.71	75.78	32.94	34.99	24.75
Debt Growth	13.09%	130.07%	-5.87%	41.38%	-
Retained Earnings	-230.07	-166.75	-96.11	-52.28	-31.41
Comprehensive Income	0	-0.01	0	0	0
Shareholders' Equity	53.77	58.58	121.35	-51.03	-30.16
Net Cash / Debt	-1.88	5.74	80.44	-17.99	-3.09
Net Cash / Debt Growth	-	-92.87%	-	-	-
Net Cash Per Share	-0.04	0.15	2.99	-7.59	-1.36
Working Capital	86.45	75.14	113.13	11.53	19.72
Book Value Per Share	1.21	1.55	4.51	-21.52	-13.25

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).